First in Human Study of NI-0701 in Healthy Volunteers
NCT01255501 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2010-12-07
Summary
The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
NI-0701
- DRUG
Sponsors & Collaborators
-
Light Chain Bioscience - Novimmune SA
lead INDUSTRY
Principal Investigators
-
John Lambert, MD · PXL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Phase 1 Study of JADE101 in Healthy Participants
NCT07059312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants
NCT04593121 ·Status: COMPLETED ·Phase: PHASE1
-
A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers
NCT02873767 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants
NCT07222709 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers
NCT04238364 ·Status: COMPLETED ·Phase: PHASE1
-
A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers
NCT02879877 ·Status: COMPLETED ·Phase: PHASE1
-
First-in-Human Trial of Oral AN2-502998
NCT07024589 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People
NCT07029568 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants
NCT06311760 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL201 in Healthy Volunteers
NCT04551534 ·Status: COMPLETED ·Phase: PHASE1
-
First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100
NCT01028521 ·Status: COMPLETED ·Phase: PHASE1
-
A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374
NCT02245828 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
NCT07219368 ·Status: RECRUITING ·Phase: PHASE1
-
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
NCT05096598 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Study of YN001 in Healthy Volunteers
NCT05635084 ·Status: COMPLETED ·Phase: PHASE1
-
First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers
NCT05275855 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate LIFE-001
NCT06904807 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.
NCT04958291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants
NCT04628793 ·Status: COMPLETED ·Phase: PHASE1
-
MT1013 Clinical TRIAL In Healthy Subject
NCT04783090 ·Status: COMPLETED ·Phase: PHASE1
-
First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers
NCT06918925 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.
NCT00749333 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101
NCT04111666 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants
NCT06555601 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants
NCT06775327 ·Status: COMPLETED ·Phase: PHASE1